TD Cowen Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV)

Go back to TD Cowen Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV)
(NASDAQ: ACRV) Delayed: 2.15 +0.08 (3.86%)
Previous Close $2.07    52 Week High
Open $2.07    52 Week Low
Day High $2.20    P/E N/A 
Day Low $2.05    EPS
Volume 131,320